SCHEMBL3390818

SCHEMBL3390818

Cc1cc2c(c(Cl)c1O)Oc1c(cc(C)c(O)c1Cl)C21OC(=O)c2ccc(C(=O)O)cc21

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 5/20 0.41
MEN1 O00255 5/20 0.41
KMT2A Q03164 5/20 0.41
RECQL P46063 4/20 0.41
THRB P10828 3/20 0.41
BLM P54132 3/20 0.41
L3MBTL1 Q9Y468 2/20 0.41
ACE2 Q9BYF1 2/20 0.41
PRMT1 Q99873 2/20 0.41
USP2 O75604 2/20 0.41
CDK2 P24941 1/20 0.41
CHAT P28329 1/20 0.41
BLVRB P30043 1/20 0.41
RXFP1 Q9HBX9 1/20 0.41
GAA P10253 1/20 0.41
PKM P14618 1/20 0.41
MAPT P10636 5/20 0.39
LMNA P02545 4/20 0.39
POLB P06746 2/20 0.39
NPSR1 Q6W5P4 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6823049 0.89 RECQL (0.43) TDP1MEN1KMT2ARECQLTHRB
SCHEMBL202849 0.88 RECQL (0.42) TDP1MEN1KMT2ARECQLTHRB
SCHEMBL29838713 0.86 MEN1 (0.39) TDP1MEN1KMT2ARECQLTHRB
SCHEMBL16118 0.86 MEN1 (0.39) TDP1MEN1KMT2ARECQLTHRB
SCHEMBL29353753 0.86 MEN1 (0.39) TDP1MEN1KMT2ARECQLTHRB
SCHEMBL15019692 0.83 GNG2 (0.50) TDP1MEN1KMT2ARECQLTHRB
SCHEMBL29401708 0.83 GNG2 (0.50) TDP1MEN1KMT2ARECQLTHRB
Succinimide SCHEMBL25268120 0.80 MEN1 (0.35) TDP1MEN1KMT2ARECQLTHRB
SCHEMBL203192 0.80 GNG2 (0.43) TDP1MEN1KMT2ARECQLTHRB
SCHEMBL202968 0.79 GNG2 (0.43) TDP1MEN1KMT2ARECQLTHRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220098289-A1 THERAPEUTIC TARGET AND MONOCLONAL ANTIBODIES AGAINST IT FOR THE DIAGNOSIS AND TREATMENT OF ALZHEIMER'S DISEASE INSTITUTO DE SALUD CARLOS III (ES) 2022-03-31 US disclosed
WO-2020165453-A1 THERAPEUTIC TARGET AND MONOCLONAL ANTIBODIES AGAINST IT FOR THE DIAGNOSIS AND TREATMENT OF ALZHEIMER´S DISEASE CONSEJO SUPERIOR DE INVESTIGACIONES CIENTÍFICAS (ES) 2020-08-20 WO disclosed
EP-3696192-A1 THERAPEUTIC TARGET AND MONOCLONAL ANTIBODIES AGAINST IT FOR THE DIAGNOSIS AND TREATMENT OF ALZHEIMER´S DISEASE Consejo Superior De Investigaciones Científicas (ES) 2020-08-19 EP disclosed
EP-3514166-A1 METHOD FOR THE DETECTION AND/OR QUANTIFICATION OF LUPIN BETA-CONGLUTIN ALLERGEN PROTEINS Consejo Superior de Investigaciones Cientificas (CSIC) (ES) 2019-07-24 EP disclosed
US-20140287418-A1 COMPOSITION FOR AMPLIFYING NUCLEIC ACIDS BIO-RAD INNOVATIONS (FR) 2014-09-25 US disclosed
EP-1815013-B1 COMPOSITION FOR AMPLIFYING NUCLEIC ACIDS BIO RAD PASTEUR (FR) 2010-12-29 EP disclosed
US-20080020396-A1 Composition For Amplifying Nucleic Acids BIO-RAD EUROPE GMBH (CH) 2008-01-24 US disclosed